Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.naturalbiocon.in | |
Market Cap | 12.45 Cr. | |
Enterprise Value(EV) | 12.64 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.33 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 33.48 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 82.08 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 10.98 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 1.00 | Calculated using Price: 10.95 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.14 Cr. | 11,372,800 Shares |
FaceValue | 10 | |
About Natural Biocon (India) Ltd. | ||
The company is engaged in the business of chemicals, natural extracts and agricultural produces. |
1 Day |
|
+1.39% |
1 Week |
|
+3.39% |
1 Month |
|
+15.70% |
3 Month |
|
+15.09% |
6 Month |
|
+81.19% |
1 Year |
|
+131.16% |
2 Year |
|
-32.84% |
5 Year |
|
|
10 Year |
|
7 years | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 0.67 | 5.99 | 0.60 | -0.26 | 0.02 | 0.55 | 1.48 | |
Return on Capital Employed (%) | 0.95 | 8.56 | 0.98 | -0.25 | 0.03 | 0.72 | 2.02 | |
Return on Assets (%) | 0.66 | 5.85 | 0.57 | -0.25 | 0.02 | 0.53 | 1.39 |
Particulars | 8 years | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 11 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | |
Non Curr. Liab. | |||||||||
Curr. Liab. | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 2 | |
Minority Int. | |||||||||
Equity & Liab. | 12 | 12 | 13 | 13 | 12 | 12 | 14 | 14 | |
Non Curr. Assets | 10 | 10 | 11 | 11 | 11 | 11 | 11 | 12 | |
Curr. Assets | 1 | 2 | 2 | 2 | 2 | 1 | 2 | 3 | |
Misc. Exp. not W/O | |||||||||
Total Assets | 12 | 12 | 13 | 13 | 12 | 12 | 14 | 14 |
Particulars | 8 years | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 0 | 1 | 0 | 0 | 0 | 1 | 5 | ||
Other Income | 0 | ||||||||
Total Income | 0 | 1 | 0 | 0 | 0 | 1 | 5 | ||
Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -4 | |
PBIDT | 0 | 1 | 0 | 0 | 0 | 0 | 0 | ||
Interest | |||||||||
Depreciation | |||||||||
Taxation | 0 | 0 | 0 | 0 | 0 | 0 | |||
Exceptional Items | |||||||||
PAT | 0 | 1 | 0 | 0 | 0 | 0 | 0 | ||
Adjusted EPS | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
Particulars | 7 years | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | -1 | 0 | 0 | 0 | 0 | |
Cash Fr. Inv. | ||||||||
Cash Fr. Finan. | 0 | 0 | 1 | 0 | 0 | 0 | 0 | |
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | ||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tue, 07 Nov 2023
Board Meeting Outcome for Meeting Of Board Of Director Held On November 07 2023. 1) Un-Audited Financial Results (UFR) for the second quarter and half year ended September 30 2023 along with the Statutory Auditors Limited Review Report. 2) Reviewed the disclosure of related party transactions for the first half year ended on September 30 2023.3) Reviewed the other businesses of the company. |
Tue, 07 Nov 2023
Financial Result For The Second Quarter And Half Year Ended September 30 2023. Unaudited Financial Result for the Second Quarter and Half Year Ended September 30 2023. |
Fri, 03 Nov 2023
Results-Delay in Financial Results Postponement of Board Meeting for adoption of Unaudited Financial Result for the Second Quarter and Half Year ended September 30 2023. |
Fri, 08 Dec 2023 |
|
|
|
|
|